Alamar Biosciences (ALMR) vs Harvard Bioscience (HBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.84 billion vs $39.6 million), about 46.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | HBIO |
|---|---|---|
| Share price | $26.48 | $8.66 |
| Market cap | $1.84B | $39.60M |
| 1-day change | -7.67% | -0.23% |
| YTD return | — | +29.25% |
| 1-year return | — | +37.46% |
| 5-year return | — | -87.45% |
| Forward P/E | — | 16.34 |
| EPS (TTM) | $-1.13 | $-2.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $86.55M |
| Revenue growth (YoY) | — | -8.06% |
| Net income (latest FY) | — | $-56.70M |
| Gross margin | — | 57.67% |
| Operating margin | — | -56.13% |
| Net margin | — | -65.51% |
| 52-week high | $39.61 | $10.20 |
| 52-week low | $18.85 | $4.00 |
| Distance from 52-week high | -33.15% | -15.10% |
| Analyst consensus | buy | none |
| Avg. price target upside | +39.73% | -13.39% |
| Average volume | 628.70K | 21.82K |
| Shares outstanding | 69.48M | 4.57M |
| Employees | 308 | 316 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 46.5 times larger than Harvard Bioscience by market value ($1.84B vs $39.60M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 308 employees
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees
ALMR vs HBIO FAQ
Which is bigger, Alamar Biosciences or Harvard Bioscience?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.84B compared with $39.60M for Harvard Bioscience (HBIO).
Are Alamar Biosciences and Harvard Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.